New RSV therapies may accelerate the emergence of drug-resistant strains: GlobalData
Antibody-resistant mutations have already been documented in RSV after the administration of AstraZeneca/Sanofi's new RSV mAb,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.